Total Payments
$2,690
2024 Payments
$66.98
Companies
25
Transactions
132
Medicare Patients
4,548
Medicare Billing
$472,970
Payment Breakdown by Category
Food & Beverage$2,685 (99.8%)
Education$4.77 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,685 | 121 | 99.8% |
| Education | $4.77 | 3 | 0.2% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
General
$2,690
124 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $592.33 | 31 | $0 (2020) |
| Janssen Biotech, Inc. | $442.33 | 27 | $0 (2020) |
| Medtronic, Inc. | $236.30 | 10 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $225.85 | 5 | $0 (2019) |
| Amgen Inc. | $157.57 | 4 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $125.75 | 6 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $112.72 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $107.15 | 6 | $0 (2020) |
| Cook Medical LLC | $105.22 | 1 | $0 (2019) |
| TOLMAR Pharmaceuticals, Inc. | $105.22 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66.98 | 5 | Medtronic, Inc. ($66.98) |
| 2023 | $53.29 | 3 | Medtronic, Inc. ($53.29) |
| 2022 | $28.42 | 2 | Medtronic, Inc. ($28.42) |
| 2021 | $128.58 | 7 | Medtronic, Inc. ($87.61) |
| 2020 | $314.98 | 18 | Astellas Pharma US Inc ($120.64) |
| 2019 | $1,075 | 49 | Astellas Pharma US Inc ($207.52) |
| 2018 | $831.85 | 42 | Astellas Pharma US Inc ($242.70) |
| 2017 | $190.42 | 6 | Endo Pharmaceuticals Inc. ($149.86) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/04/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/12/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 08/23/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 01/19/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/01/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 10/28/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/19/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/12/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/10/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/05/2021 | BOSTON SCIENTIFIC CORPORATION | SPACEOAR VUE (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/10/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 2021 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/18/2020 | Boston Scientific Corporation | SPACEOAR (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: BPH | ||||||
| 12/02/2020 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Oncology | ||||||
| 09/15/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: UROLOGY | ||||||
| 09/02/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/01/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2020 | Axonics Modulation Technologies, Inc. | Axonics r-SNM System (Device) | Food and Beverage | In-kind items and services | $36.74 | General |
| Category: Urology | ||||||
| 03/03/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,063 | 1,523 | $494,745 | $124,142 |
| 2022 | 16 | 885 | 1,152 | $465,771 | $131,260 |
| 2021 | 18 | 1,255 | 1,605 | $413,252 | $137,902 |
| 2020 | 15 | 1,345 | 1,861 | $279,331 | $79,665 |
Total Patients
4,548
Total Services
6,141
Medicare Billing
$472,970
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 499 | $100,393 | $31,572 | 31.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 28 | 165 | $112,479 | $21,691 | 19.3% |
| 53850 | Destruction of prostate tissue using microwave induced heat | Office | 2023 | 18 | 18 | $87,978 | $18,841 | 21.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 87 | $48,684 | $15,017 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 139 | 139 | $42,097 | $10,394 | 24.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 12 | 14 | $24,754 | $6,178 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 42 | $12,474 | $4,183 | 33.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 40 | 42 | $10,301 | $3,542 | 34.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 41 | 47 | $13,160 | $3,024 | 23.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 44 | $8,756 | $2,704 | 30.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 202 | 269 | $13,419 | $2,165 | 16.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 44 | $7,911 | $1,888 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $6,042 | $1,315 | 21.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 25 | 39 | $3,159 | $927.11 | 29.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 30 | $2,000 | $526.35 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 13 | $832.00 | $137.76 | 16.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 18 | $306.00 | $35.86 | 11.7% |
| 53850 | Destruction of prostate tissue using microwave induced heat | Office | 2022 | 30 | 30 | $143,280 | $35,741 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 282 | 365 | $79,041 | $22,154 | 28.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 98 | 112 | $59,766 | $21,298 | 35.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 28 | 132 | $62,106 | $17,832 | 28.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 183 | 183 | $55,419 | $13,855 | 25.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 59 | 62 | $14,664 | $5,894 | 40.2% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 21 | 21 | $11,466 | $3,804 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 34 | $10,045 | $3,123 | 31.1% |
About Dr. John Pearson, MD
Dr. John Pearson, MD is a Urology healthcare provider based in South Hill, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497731343.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Pearson, MD has received a total of $2,690 in payments from pharmaceutical and medical device companies, with $66.98 received in 2024. These payments were reported across 132 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,685).
As a Medicare-enrolled provider, Pearson has provided services to 4,548 Medicare beneficiaries, totaling 6,141 services with total Medicare billing of $472,970. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location South Hill, VA
- Active Since 12/21/2005
- Last Updated 09/28/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497731343
Products in Payments
- Erleada (Drug) $497.94
- INTERSTIM (Device) $257.73
- MYRBETRIQ (Drug) $237.78
- Prolia (Biological) $157.57
- XIAFLEX (Biological) $149.86
- XTANDI (Drug) $137.75
- VESICARE (Drug) $113.14
- Cook Medical Holmium Laser Fiber (Device) $105.22
- ELIGARD (Drug) $105.22
- PROVENGE (Drug) $104.96
- AVEED (Biological) $75.99
- Xofigo (Drug) $65.66
- Lupron Depot (Drug) $57.82
- ERLEADA (Drug) $57.11
- FIRMAGON (Drug) $56.59
- Osphena (Drug) $48.89
- TOVIAZ (Drug) $47.49
- REZUM (Device) $42.06
- Nubeqa (Drug) $41.49
- Axonics r-SNM System (Device) $36.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.